Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports

Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports

The management of castrate-resistant prostate cancer progressing after maximum androgen blockade (MAB) has evolved in the last decade with the development of several novel therapeutic options. However, the initial therapeutic strategy in these patients usually involves withdrawal of anti-androgen th...

Full description

Bibliographic Details
Main Authors: Hingorani, Mohan, Dixit, Sanjay, Bashir, Fahim, Butt, Mohammad, Hawkyard, Simon, Khafagy, Richard, Robertson, Andrew
Format: Online
Language:English
Published: Chinese Anti-Cancer Association 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296085/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296085/

Similar Items